Consumers are being warned about two new recalls of eyedrops due to contamination hazards that could cause significant damage and eyesight impairment.
The announcements come after last month’s recall of eyedrops made in India connected to an epidemic of illnesses with antibiotic resistance.
At least five additional people had irreversible eyesight loss, and one individual passed away.
There is no evidence that the most recent recalls are connected to those goods.
Following the firms’ announcements that they voluntarily removed numerous batches of their goods from the market, the Food and Drug Administration published separate recall notifications for specific eyedrops marketed by Pharmedica and Apotex.
The over-the-counter drops are intended to cure eye irritation, but Pharmedica announced on Friday that it recalls two lots of Perfectly Soothing 15% MSM Drops due to issues “that could result in blindness.”
The Phoenix-based company advised customers to cease using the drops and return them to the store where they were bought.
This Monday, the FDA posted a separate recall statement from Apotex recalling six lots of prescription eyedrops intended to treat a form of glaucoma. The business started the recall after discovering cracks in a few bottle caps.
Brimonidine Tartrate Ophthalmic Solution is the name of the liquid that is distributed. 0.15% and were distributed from April 2017 to February 2018.
According to both businesses, the FDA was consulted before conducting the recalls. Emails requesting comments from company representatives received no response right away.